346 related articles for article (PubMed ID: 28630383)
41. Echinococcus granulosus glycoconjugates induce peritoneal B cell differentiation into antibody-secreting cells and cytokine production.
Mourglia-Ettlin G; Amezcua-Vesely MC; Fraga R; Baz A; Merino MC; Gruppi A; Dematteis S
Parasite Immunol; 2011 Nov; 33(11):621-31. PubMed ID: 21992445
[TBL] [Abstract][Full Text] [Related]
42. Production of monoclonal antibodies against the 8 kDa subunit of Echinococcus granulosus Antigen B (EgAgB8/2) using DNA immunization.
Al-Qaoud KM; Al-Omari MM; Al-Aghbar M; Abdel-Hafez SK
Hybridoma (Larchmt); 2008 Dec; 27(6):431-8. PubMed ID: 18803505
[TBL] [Abstract][Full Text] [Related]
43. Activity in mice of recombinant BCG-EgG1Y162 vaccine for Echinococcus granulosus infection.
Ma X; Zhao H; Zhang F; Zhu Y; Peng S; Ma H; Cao C; Xin Y; Yimiti D; Wen H; Ding J
Hum Vaccin Immunother; 2016; 12(1):170-5. PubMed ID: 26266551
[TBL] [Abstract][Full Text] [Related]
44. Current situation and future prospects of Echinococcus granulosus vaccine candidates: A systematic review.
Anvari D; Rezaei F; Ashouri A; Rezaei S; Majidiani H; Pagheh AS; Rezaei F; Shariatzadeh SA; Fotovati A; Siyadatpanah A; Gholami S; Ahmadpour E
Transbound Emerg Dis; 2021 May; 68(3):1080-1096. PubMed ID: 32762075
[TBL] [Abstract][Full Text] [Related]
45. Serological monitoring of protection of sheep against Echinococcus granulosus induced by the EG95 vaccine.
Heath DD; Koolaard J
Parasite Immunol; 2012 Jan; 34(1):40-4. PubMed ID: 22043983
[TBL] [Abstract][Full Text] [Related]
46. An oral recombinant vaccine in dogs against Echinococcus granulosus, the causative agent of human hydatid disease: a pilot study.
Petavy AF; Hormaeche C; Lahmar S; Ouhelli H; Chabalgoity A; Marchal T; Azzouz S; Schreiber F; Alvite G; Sarciron ME; Maskell D; Esteves A; Bosquet G
PLoS Negl Trop Dis; 2008 Jan; 2(1):e125. PubMed ID: 18235847
[TBL] [Abstract][Full Text] [Related]
47. [Demonstration of host-parasite common antigens in hydatidosis].
Bouchara JP; Robert R; Senet JM; Leynia de La Jarrige P
Bull Soc Pathol Exot Filiales; 1985; 78(5 Pt 2):707-11. PubMed ID: 2425994
[TBL] [Abstract][Full Text] [Related]
48. [Dynamic observation on splenocyte subsets in mice immunized with recombinant Bb-Eg95-EgA31 vaccine of Echinococcus granulosus].
Zhou BY; Chen YT; Li WG; Yang M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):764-6. PubMed ID: 21302436
[TBL] [Abstract][Full Text] [Related]
49. Parasite molecules and host responses in cystic echinococcosis.
Díaz A; Casaravilla C; Barrios AA; Ferreira AM
Parasite Immunol; 2016 Mar; 38(3):193-205. PubMed ID: 26425838
[TBL] [Abstract][Full Text] [Related]
50. Detection of Echinococcus granulosus sensu lato infection by using extracts derived from a protoscoleces G1 cell line.
Maglioco A; Gentile J; Barbery Venturi MS; Jensen O; Hernández C; Gertiser ML; Poggio V; Canziani G; Fuchs AG
Parasite Immunol; 2019 Dec; 41(12):e12674. PubMed ID: 31557338
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of rabbit antibody response against 8 and 16 kDa recombinant subunits of antigen B from Echinococcus granulosus.
Abdi J; Kazemi B; Karimfar MH; Rokni MB
Asian Pac J Trop Med; 2012 May; 5(5):355-7. PubMed ID: 22546650
[TBL] [Abstract][Full Text] [Related]
52. Vaccination with rEGVac elicits immunoprotection against different stages of Echinococcus granulosus life cycle: A pilot study.
Pourseif MM; Moghaddam G; Nematollahi A; Khordadmehr M; Naghili B; Dehghani J; Omidi Y
Acta Trop; 2021 Jun; 218():105883. PubMed ID: 33676937
[TBL] [Abstract][Full Text] [Related]
53. Thioredoxin peroxidase secreted by Echinococcus granulosus (sensu stricto) promotes the alternative activation of macrophages via PI3K/AKT/mTOR pathway.
Wang H; Zhang CS; Fang BB; Li ZD; Li L; Bi XJ; Li WD; Zhang N; Lin RY; Wen H
Parasit Vectors; 2019 Nov; 12(1):542. PubMed ID: 31727141
[TBL] [Abstract][Full Text] [Related]
54. Excretory/secretory products from in vitro-cultured Echinococcus granulosus protoscoleces.
Virginio VG; Monteiro KM; Drumond F; de Carvalho MO; Vargas DM; Zaha A; Ferreira HB
Mol Biochem Parasitol; 2012 May; 183(1):15-22. PubMed ID: 22261090
[TBL] [Abstract][Full Text] [Related]
55. [Cloning and expression of echinococcus granulosus Eg18 and preliminary evaluation of immunological assay with recombinant antigen].
Wang YS; Han XM; Wang H
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Apr; 23(2):192-6. PubMed ID: 22164626
[TBL] [Abstract][Full Text] [Related]
56. Echinococcus granulosus: use of an intermediate host mouse model to evaluate sources of protective antigens and a role for antibody in the immune response.
Dempster RP; Harrison GB; Berridge MV; Heath DD
Int J Parasitol; 1992 Jul; 22(4):435-41. PubMed ID: 1644518
[TBL] [Abstract][Full Text] [Related]
57. Vaccination of bovines against Echinococcus granulosus (cystic echinococcosis).
Heath DD; Robinson C; Shakes T; Huang Y; Gulnur T; Shi B; Zhang Z; Anderson GA; Lightowlers MW
Vaccine; 2012 Apr; 30(20):3076-81. PubMed ID: 22406459
[TBL] [Abstract][Full Text] [Related]
58. Proteomic characterization of larval and adult developmental stages in Echinococcus granulosus reveals novel insight into host-parasite interactions.
Cui SJ; Xu LL; Zhang T; Xu M; Yao J; Fang CY; Feng Z; Yang PY; Hu W; Liu F
J Proteomics; 2013 Jun; 84():158-75. PubMed ID: 23603110
[TBL] [Abstract][Full Text] [Related]
59. [Change of splenocyte lymphokines in mice induced by recombinant BCG-Eg95 vaccine against Echinococcus granulosus].
Li WG; Wang H; Zhu YM
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Apr; 25(2):109-13. PubMed ID: 17633820
[TBL] [Abstract][Full Text] [Related]
60. [Physiological characteristics of Echinococcus and their association with interventions against echinococcosis].
Li J; Guo G; Zhang ZZ; Zhang WB
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Feb; 52(2):210-214. PubMed ID: 29429281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
